Dr. Swetha Yadav, MD – Houston, TX
Sarah Parker education
Morphoproteomics confirms the mTORC2 Pathway as a Resistance Signature and Activated ERK and STAT3 Prosurvival/Antiapoptotic Pathways in Metastatic Renal Cell Carcinom...
Swetha Yadav, M.D., Jamie Buryanek, M.D. Robert E. Brown, M.D., Fangqian Ouyang, Robert Amato, D.O, Journal of Clinical Oncology, 1/1/2013Phase II Trial of Cetuximab With or Without Paclitaxel in Patients With Advanced Urothelial Tract Carcinoma
Yu-Ning Wong, Samuel Litwin, David Vaughn, Seth Cohen, Elizabeth R. Plimack, James Lee, Wei Song, Journal Club, 1/1/2012Asymmetric Dimethylarginine: The missing link between Chronic Kidney Disease and Cardiovascular Mortality?
Swetha S Yadav, Carolyn Brecklin, Kidney, a current survey of world literature, 1/1/2007
